Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Neurogenesis and Regeneration of Nervous Tissue

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correlation Between Quantitative Pupillometry and Other Markers for Neuroprognostication of Comatose Patients After Cardiac Arrest: A Bicentric Study.

Critical care medicine·2026

Same author

Status Epilepticus Is Detected Earlier than Seizures on cEEG in Critically Ill Adults.

Neurocritical care·2026

Same author

Effects of midazolam and propofol on EEG detection of epileptiform activity in patients with altered consciousness.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026

Same author

Sex Disparities in the Clinical Management and Outcomes of Critically Ill Adults Undergoing Electroencephalography Monitoring.

Critical care medicine·2026

Same author

Brainstem Respiratory Center Dysfunction in Persons With Epilepsy: An fMRI Study.

Neurology·2026

Same author

[Neurology : what's new in 2025].

Revue medicale suisse·2026

Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026

Same journal

[Integrative medicine : a structured referral framework for general practitioners].

Revue medicale suisse·2026

Same journal

[Targeted therapy for ultra-rare diseases].

Revue medicale suisse·2026

Same journal

[Inherited metabolic diseases in adults : from diagnosis to treatment].

Revue medicale suisse·2026

Same journal

[Cardiogenetics in clinical practice : challenges, indications, and perspectives].

Revue medicale suisse·2026

Same journal

[Genetic medicine illustrated by three key syndromes].

Revue medicale suisse·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 19, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

[Recent Advances in Neurology].

Angelica Anichini¹, Paolo Salvioni Chiabotti¹, Julien Bally¹

¹Service de neurologie, Département des neurosciences cliniques, CHUV, 1011 Lausanne.

Revue Medicale Suisse

|January 28, 2021

Summary

This summary is machine-generated.

2020 saw major advances in neurological research, including blood biomarkers for Alzheimer's disease and new treatments for Parkinson's disease and migraine. Updates also covered epilepsy management, stroke care, and COVID-19 neurological effects.

More Related Videos

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain

Published on: January 27, 2022

Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model

Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model

Published on: December 28, 2021

Related Experiment Videos

Last Updated: Nov 19, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain

Published on: January 27, 2022

Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model

Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model

Published on: December 28, 2021

Area of Science:

Neurology
Neuroscience
Biomarkers

Background:

2020 marked a significant year for neurological research and clinical practice.
Key areas saw substantial advancements, impacting diagnosis, treatment, and patient management.

Purpose of the Study:

To summarize key developments in neurology published in 2020.
To highlight progress in Alzheimer's disease, epilepsy, stroke, NMO-SD, COVID-19 neurology, migraine, and Parkinson's disease.

Main Methods:

Review of significant publications and guideline updates from 2020.
Synthesis of findings across diverse neurological subspecialties.

Main Results:

Established blood biomarkers for Alzheimer's disease.
Improved management strategies for status epilepticus and epilepsy in women.
New Swiss pre-hospital stroke guidelines and prevention targets.
Advances in NeuroMyelitis Optica Spectrum Disorder (NMO-SD) management.
Characterization of neurological manifestations of COVID-19.
Confirmation of efficacy for new anti-CGRP migraine treatments.
Introduction of novel pharmacological therapies for Parkinson's disease.

Conclusions:

2020 was a pivotal year for neurology, with significant progress across multiple domains.
These advancements offer improved diagnostic and therapeutic options for various neurological conditions.